AGRN activates GPX4 via the Wnt/beta-catenin signaling pathway to suppress ferroptosis in cervical cancer cells
Briefings in Functional Genomics · 2026
DOI: 10.1093/bfgp/elag010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Briefings in Functional Genomics, 2026. Verfasst von Aizhen Fu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Affiliated Hospital of Guangdong Medical University, No. 57 Renmin Avenue South, Xiashan District, Zhanjiang…. Hauptthemen laut MEDLINE: Ferroptosis, Uterine Cervical Neoplasms, Phospholipid Hydroperoxide Glutathione Peroxidase, Wnt Signaling Pathway. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Zhanjiang City Science and Technology Plan Project.
Abstract (Originalsprache)
Cervical cancer remains a leading cause of cancer-related deaths among women worldwide. Targeting ferroptosis, a regulated form of cell death driven by lipid peroxidation, has emerged as a promising therapeutic strategy. This study aimed to elucidate the mechanisms by which cervical cancer cells acquire resistance to ferroptosis. AGRN expression and its prognostic significance were analyzed in cervical cancer using TCGA and GTEx data. In vitro, AGRN levels were measured in HeLa, CaSki, and Ect1/E6E7 cells via qRT-PCR. mRNA and protein expression levels of AGRN, beta-catenin, and ferroptosis-related markers were evaluated by qRT-PCR and western blot (WB). Cell viability, RSL3 sensitivity (IC50), and lipid ROS were assessed via CCK-8 assay and flow cytometry. In a xenograft model, RSL3’s effect on tumor growth was examined. Immunohistochemistry (IHC) and molecular analyses (qRT-PCR, WB, and flow cytometry) were performed on tumor tissues to evaluate AGRN, beta-catenin, Ki-67, ferroptosis-related genes, and lipid ROS. It is found through research that, AGRN was significantly upregulated in cervical cancer tissues and cell lines. Its overexpression activated Wnt/beta-catenin signaling, resulting in elevated GPX4 and SLC7A11 levels and reduced CHAC1 and PTGS2 expression levels. These alterations decreased lipid ROS accumulation and enhanced resistance to RSL3-induced ferroptosis, an effect further confirmed in xenograft models. In short, In short, AGRN promotes ferroptosis resistance in cervical cancer by activating the Wnt/beta-catenin signaling pathway and upregulating GPX4 expression. Targeting the AGRN–Wnt/beta-catenin–GPX4 axis may represent a novel therapeutic approach for cervical cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Affiliated Hospital of Guangdong Medical University, No. 57 Renmin Avenue South, Xiashan District, Zhanjiang, Guangdong 524000, China.
- Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Guangdong Medical University, No. 12 Minyou Road, Xiashan District, Zhanjiang, Guangdong 524000, China.
- Department of Oncology, Zhujiang Hospital, Southern Medical University, No. 253 Industrial Avenue, Haizhu District, Guangzhou, Guangdong 510282, China.
ORCID-Profile: Bingfang Mai
Förderung
- Zhanjiang City Science and Technology Plan Project
Zitieren
APA
Fu, A., Cai, J., Chen, R., Zou, X., Chen, Y., Fu, F., Zhang, W., Huang, L., Ye, Y., Li, R., & Mai, B. (2026). AGRN activates GPX4 via the Wnt/beta-catenin signaling pathway to suppress ferroptosis in cervical cancer cells. Briefings in Functional Genomics. https://doi.org/10.1093/bfgp/elag010
Vancouver
Fu A, Cai J, Chen R, Zou X, Chen Y, Fu F, et al. AGRN activates GPX4 via the Wnt/beta-catenin signaling pathway to suppress ferroptosis in cervical cancer cells. Briefings in Functional Genomics. 2026. doi:10.1093/bfgp/elag010
BibTeX
@article{Fu2026,
author = {Fu, Aizhen and Cai, Jiayi and Chen, Ruitao and Zou, Xinxin and Chen, Yongfeng and Fu, Fengping and Zhang, Wen and Huang, Lin and Ye, Yuan and Li, Renhe and Mai, Bingfang},
title = {AGRN activates GPX4 via the Wnt/beta-catenin signaling pathway to suppress ferroptosis in cervical cancer cells},
journal = {Briefings in Functional Genomics},
year = {2026},
doi = {10.1093/bfgp/elag010}
}
EUVIMED